Literature DB >> 7575249

Bilateral acute angle-closure glaucoma associated with drug sensitivity to hydrochlorothiazide.

J D Geanon, T W Perkins.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7575249     DOI: 10.1001/archopht.1995.01100100019012

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


× No keyword cloud information.
  7 in total

1.  Bilateral acute angle closure glaucoma associated with hydrochlorothiazide-induced hyponatraemia.

Authors:  Sylvia H Chen; Rustum Karanjia; Robert L Chevrier; David H Marshall
Journal:  BMJ Case Rep       Date:  2014-12-04

2.  Acute-onset bilateral myopia and ciliochoroidal effusion induced by hydrochlorothiazide.

Authors:  Young-Rae Roh; Se Joon Woo; Kyu Hyung Park
Journal:  Korean J Ophthalmol       Date:  2011-05-24

3.  Traumatic myopia secondary to ciliary spasm after blunt eye trauma and reconsideration of its pathogenesis.

Authors:  Naohiro Ikeda; Tomohiro Ikeda; Takeya Kohno
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-02-10       Impact factor: 3.117

Review 4.  Molecular pharmacodynamics, clinical therapeutics, and pharmacokinetics of topiramate.

Authors:  Richard P Shank; Bruce E Maryanoff
Journal:  CNS Neurosci Ther       Date:  2008       Impact factor: 5.243

Review 5.  Drug-induced glaucomas: mechanism and management.

Authors:  Ramesh C Tripathi; Brenda J Tripathi; Chris Haggerty
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

6.  Angiographic features of drug-induced bilateral angle closure and transient myopia with Ciliochoroidal effusion.

Authors:  Yong Koo Kang; Byeong Jae Son; Dong Ho Park; Jae Pil Shin
Journal:  BMC Ophthalmol       Date:  2019-11-04       Impact factor: 2.209

7.  Mefenamic acid-induced bilateral transient myopia, secondary angle closure glaucoma and choroidal detachment.

Authors:  Parag Vishwakarma; Ganesh V Raman; P Sathyan
Journal:  Indian J Ophthalmol       Date:  2009 Sep-Oct       Impact factor: 1.848

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.